315 related articles for article (PubMed ID: 35801264)
1. Global trends, regional differences and age distribution for the incidence of HIV and tuberculosis co-infection from 1990 to 2019: results from the global burden of disease study 2019.
Wang Y; Jing W; Liu J; Liu M
Infect Dis (Lond); 2022 Nov; 54(11):773-783. PubMed ID: 35801264
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in the global burden of multidrug- resistant tuberculosis without extensive drug resistance in the general population and people living with HIV/AIDS, 1990-2019.
Choi J; Park J; Son Y; Kim S; Kwon R; Lee H; Rahmati M; Kang J; Woo HG; Koyanagi A; Smith L; López Sánchez GF; Dragioti E; Lee SH; Cho W; Kim HJ; Shin JI; Yon DK
Eur Rev Med Pharmacol Sci; 2024 May; 28(10):3669-3682. PubMed ID: 38856143
[TBL] [Abstract][Full Text] [Related]
3. Global trends in the incidence rates of MDR and XDR tuberculosis: Findings from the global burden of disease study 2019.
Bu Q; Qiang R; Fang L; Peng X; Zhang H; Cheng H
Front Pharmacol; 2023; 14():1156249. PubMed ID: 36909179
[No Abstract] [Full Text] [Related]
4. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
[TBL] [Abstract][Full Text] [Related]
5. Management of drug resistantTB in patients with HIV co-infection.
Pontali E; Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
Expert Opin Pharmacother; 2015; 16(18):2737-50. PubMed ID: 26478945
[TBL] [Abstract][Full Text] [Related]
6. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
7. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China.
He XC; Tao NN; Liu Y; Zhang XX; Li HC
BMC Infect Dis; 2017 Aug; 17(1):555. PubMed ID: 28793873
[TBL] [Abstract][Full Text] [Related]
10. High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers.
O'Donnell MR; Jarand J; Loveday M; Padayatchi N; Zelnick J; Werner L; Naidoo K; Master I; Osburn G; Kvasnovsky C; Shean K; Pai M; Van der Walt M; Horsburgh CR; Dheda K
Ann Intern Med; 2010 Oct; 153(8):516-22. PubMed ID: 20956708
[TBL] [Abstract][Full Text] [Related]
11. Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa.
Migliori GB; Dheda K; Centis R; Mwaba P; Bates M; O'Grady J; Hoelscher M; Zumla A
Trop Med Int Health; 2010 Sep; 15(9):1052-66. PubMed ID: 20545927
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
Gandhi NR; Andrews JR; Brust JC; Montreuil R; Weissman D; Heo M; Moll AP; Friedland GH; Shah NS
Int J Tuberc Lung Dis; 2012 Jan; 16(1):90-7. PubMed ID: 22236852
[TBL] [Abstract][Full Text] [Related]
13. Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
Chen Y; Liu J; Zhang Q; Chen H; Chai L; Wang Y; Zhang J; Qiu Y; Shen N; Shi X; Wang Q; Wang J; Li S; Li M
Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):747-765. PubMed ID: 38367094
[TBL] [Abstract][Full Text] [Related]
14. From multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study.
Stoffels K; Allix-Béguec C; Groenen G; Wanlin M; Berkvens D; Mathys V; Supply P; Fauville-Dufaux M
PLoS One; 2013; 8(5):e63128. PubMed ID: 23671662
[TBL] [Abstract][Full Text] [Related]
15. HIV and tuberculosis co-infection in East Asia and the Pacific from 1990 to 2017: results from the Global Burden of Disease Study 2017.
Zhang J; Kern-Allely S; Yu T; Price RK
J Thorac Dis; 2019 Sep; 11(9):3822-3835. PubMed ID: 31656655
[TBL] [Abstract][Full Text] [Related]
16. Drug Resistance of
Gao W; Chen X; Yao L; Li J; Gao Y; Li T; Li Y; Wang W; Zhang S; He J
J Immunol Res; 2023; 2023():4431209. PubMed ID: 36726492
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological features and temporal trends of HIV-negative tuberculosis burden from 1990 to 2019: a retrospective analysis based on the Global Burden of Disease Study 2019.
Chen Y; Liu J; Zhang Q; Wang Q; Chai L; Chen H; Li D; Qiu Y; Wang Y; Shen N; Wang J; Xie X; Li S; Li M
BMJ Open; 2023 Sep; 13(9):e074134. PubMed ID: 37770275
[TBL] [Abstract][Full Text] [Related]
18. Laboratory-Based Surveillance of Extensively Drug-Resistant Tuberculosis in Eastern China.
Huang Y; Wu Q; Xu S; Zhong J; Chen S; Xu J; Zhu L; He H; Wang X
Microb Drug Resist; 2017 Mar; 23(2):236-240. PubMed ID: 27754791
[TBL] [Abstract][Full Text] [Related]
19. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
Chang KC; Yew WW
Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
